Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTODOSE: Short vs Long Corticosteroid Tapering in Giant Cell Arteritis
NCT04012905Phase 3Recruiting
- Sponsor
- CHU Caen Normandie
- Start
- Mar 2021
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in giant cell arteritis (GCA), sponsored by CHU Caen Normandie. Started Mar 2021; status: recruiting.
02
Drugs
prednisone
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on NCT04012905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04012905.